Patents by Inventor Michael Dorwart

Michael Dorwart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190169687
    Abstract: Provided are methods of nucleic acid sample preparation for analysis, including analysis using nanopore sequencing applications. In particular provided are methods that allow for the creation of circular and linear DNA samples that contain asymmetric ends to ligate different and desired adaptors to the end of the sample, methods to create single nucleic acid molecules that automatically form concatemers for higher sequencing throughput; methods to create multiple copies (temperature dependent, multi-primed, open-fold replication) of one original nucleic acid sample, or to create single nucleic acid molecules containing multiple copies of more than one original nucleic acid sample (concatemerized samples) for improved accuracy and throughput are described; and methods for improved modified base calling.
    Type: Application
    Filed: October 4, 2018
    Publication date: June 6, 2019
    Inventors: Randall Davis, Michael Dorwart, Janine Mok
  • Patent number: 10301361
    Abstract: Described herein are variants of alpha-hemolysin having at least one mutation selected from T12R, T12K, N17R, N17K or combinations of T12 and N17 mutations. The variants in some embodiments may further comprise H144A. The ?-hemolysin variants have a decreased time to thread.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: May 28, 2019
    Assignee: GENIA TECHNOLOGIES, INC.
    Inventors: Michael Dorwart, Daniel Korenblum
  • Publication number: 20190119745
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Application
    Filed: January 3, 2019
    Publication date: April 25, 2019
    Applicant: GENIA TECHNOLOGIES, INC.
    Inventors: Timothy Kellogg CRAIG, Cynthia Ann CECH, Michael DORWART, Liv Elisabeth JENSEN, Marshall Winston PORTER, Christos TZITZILONIS, Alexander Hyun-min YANG
  • Patent number: 10227645
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: March 12, 2019
    Assignee: GENIA TECHNOLOGIES, INC.
    Inventors: Timothy Kellogg Craig, Cynthia Ann Cech, Michael Dorwart, Liv Elisabeth Jensen, Marshall Winston Porter, Christos Tzitzilonis, Alexander Hyun-min Yang
  • Publication number: 20170241948
    Abstract: This disclosure provides chips, systems and methods for sequencing a nucleic acid sample. Tagged nucleotides are provided into a reaction chamber comprising a nanopore in a membrane. An individual tagged nucleotide of the tagged nucleotides can contain a tag coupled to a nucleotide, which tag is detectable with the aid of the nanopore. Next, an individual tagged nucleotide of the tagged nucleotides can be incorporated into a growing strand complementary to a single stranded nucleic acid molecule derived from the nucleic acid sample. With the aid of the nanopore, a tag associated with the individual tagged nucleotide can be detected upon incorporation of the individual tagged nucleotide. The tag can be detected with the aid of the nanopore when the tag is released from the nucleotide.
    Type: Application
    Filed: March 3, 2017
    Publication date: August 24, 2017
    Applicants: The Trustees of Columbia University in the City of New York, Genia Technologies, Inc.
    Inventors: Sergey Kalachikov, Jingyue Ju, Irina Morozova, Michael Dorwart
  • Publication number: 20170088588
    Abstract: Described herein are variants of alpha-hemolysin having at least one mutation selected from T12R, T12K, N17R, N17K or combinations of T12 and N17 mutations. The variants in some embodiments may further comprise H144A. The ?-hemolysin variants have a decreased time to thread.
    Type: Application
    Filed: October 28, 2015
    Publication date: March 30, 2017
    Inventors: Michael DORWART, Daniel KORENBLUM
  • Publication number: 20170088890
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Application
    Filed: September 23, 2016
    Publication date: March 30, 2017
    Inventors: Timothy Kellogg CRAIG, Cynthia Ann CECH, Michael DORWART, Liv Elisabeth JENSEN, Marshall Winston PORTER, Christos TZITZILONIS, Alexander Hyun-min YANG
  • Publication number: 20140134616
    Abstract: This disclosure provides chips, systems and methods for sequencing a nucleic acid sample. Tagged nucleotides are provided into a reaction chamber comprising a nanopore in a membrane. An individual tagged nucleotide of the tagged nucleotides can contain a tag coupled to a nucleotide, which tag is detectable with the aid of the nanopore. Next, an individual tagged nucleotide of the tagged nucleotides can be incorporated into a growing strand complementary to a single stranded nucleic acid molecule derived from the nucleic acid sample. With the aid of the nanopore, a tag associated with the individual tagged nucleotide can be detected upon incorporation of the individual tagged nucleotide. The tag can be detected with the aid of the nanopore when the tag is released from the nucleotide.
    Type: Application
    Filed: November 6, 2013
    Publication date: May 15, 2014
    Applicant: Genia Technologies, Inc.
    Inventors: Randall Davis, Roger Chen, Arkadiusz Bibillo, Daniel Korenblum, Michael Dorwart